Transdermal patches included in the interchangeable drug list
Fimea has published the interchangeable drug list for the Q2 of this year.
regulatory affairs
Familiar with promotional compliance in Sweden?
In Sweden, the person responsible for the company’s marketing activities for medicinal products must have an IMA diploma.
We are searching for a new expert to join our Pricing and reimbursement team
Please submit your CV and a short motivation letter (max. one page) by 12 February 2016 to .
New practise: Kela to collect a one-off payback fee from pharmaceutical companies in 2016
This non-recurring payback fee only applies to Kela-reimbursed actual sales.
Decree on fees chargeable by the Finnish Medicines Agency has been updated
New updated decree 252/2014 became effective as of 1 April 2014.